Impedimed

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Trading Performance

Detrended Price Oscillator

Score

-0.85

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 7 34.1 0.14% 0.17% 6.0% -13.6% -75.8%
SHORT 6 74.3 0.50% 1.00% 48.4% -12.4% 107.8%

Summary

Technical Analysis

Impedimed (IPD.AX)


Indicator:

DETREND PRICE OSCILLARTOR


Last Signal:

BULLISH


Trading: BUY @ $0.15
Signal Strength: STRONG
Recommendation:

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to highlight trends across numerous timeframes. This indicator has the ability to smooth historical results to illustrate trend initiation and status. Although this is a simple trend following indicator & can provide good results when coupled with the right indicator. Note, this indicator does not work well in ranging markets producing unwanted whipsaws and false signals.


Impedimed (ASX:IPD) currently has a confirmed uptrend. Price is currently above the displaced moving average for IPD Currently, the return on DPO20 is -3.2%.



The Detrended Price Oscillator (DPO) is an indicator designed to remove trend from price and make it easier to identify cycles. DPO does not extend to the last date because it is based on a displaced moving average. However alignment with the most recent is not an issue because DPO is not a momentum oscillator. Instead DPO is used to identify cycle’s highs/lows and estimate cycle length.

Calculation: Detrended Price Oscillator (DPO):
1) Price (X/2 + 1) periods ago minus X-period simple moving average.
Where X is the number of periods;


PROFILE: Impedimed (IPD.AX)


Stock Exchange: ASX
Company: Impedimed
Ticker Codes: | IPD.AX | ASX:IPD |

About Impedimed (ASX:IPD):

ImpediMed Limited, together with its subsidiaries, engages in the development, manufacture, and sale of bioimpedance devices and consumables in Australia, North America, Europe, and internationally. The company operates through Medical and Test & Measurement segments. It offers L-Dex U400, a technology that utilizes the characteristics of frequency dependent current flow to quantify changes in extracellular fluid in the patient's limb; and SFB7, a tetra polar bioimpedance spectroscopy device that scans various frequencies for the estimation of body composition in healthy individuals. The company also provides DF50, a single frequency body composition analysis in healthy individuals; and ImpediVET, a bioimpedance spectroscopy technology for use in veterinary applications. Its products are used in a range of applications, such as in the assessment and monitoring of secondary lymphedema, as well as monitoring of body composition and hydration. In addition, the company is involved in the supply of power precision testing and measuring equipment. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.

Top 10:

Detrended Price Oscillator

Download
Company Close Change(%) Volume Value Signal
MOY Millennium Minerals 0.13 13.6 1,861,319 0.03 BULLISH
ONE Oneview Healthcare 0.29 11.8 184,305 0.05 BULLISH
MXI Maxitra Industries 0.33 8.2 24,282 0.03 BULLISH
SLR Silver Lake Resources 1.45 8.2 9,252,383 0.53 BULLISH
RSG Resolute Mining 1.74 7.1 9,161,059 0.61 BULLISH
PRU Perseus Mining 0.71 6.8 12,414,565 0.22 BULLISH
AQG Alacer Gold Corp 5.42 6.3 936,317 1.21 BULLISH
NST Northern Star Resources 13.47 6 4,840,454 3.38 BULLISH
WAF West African Resources 0.39 5.4 3,897,020 0.09 BULLISH
SBM St Barbara Mines 3.55 5.3 5,019,351 0.6 BULLISH